169 related articles for article (PubMed ID: 8285615)
1. Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin.
Lang R; Shasha B; Rubinstein E
Antimicrob Agents Chemother; 1993 Nov; 37(11):2333-6. PubMed ID: 8285615
[TBL] [Abstract][Full Text] [Related]
2. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
[TBL] [Abstract][Full Text] [Related]
3. Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin.
Shasha B; Lang R; Rubinstein E
Antimicrob Agents Chemother; 1992 May; 36(5):973-6. PubMed ID: 1510422
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of combinations of doxycycline and rifampicin in the therapy of experimental mouse brucellosis.
Shasha B; Lang R; Rubinstein E
J Antimicrob Chemother; 1994 Mar; 33(3):545-51. PubMed ID: 8040118
[TBL] [Abstract][Full Text] [Related]
5. Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice.
Domingo S; Gastearena I; Vitas AI; López-Goñi I; Dios-Viéitez C; Díaz R; Gamazo C
J Antimicrob Chemother; 1995 Oct; 36(4):647-56. PubMed ID: 8591939
[TBL] [Abstract][Full Text] [Related]
6. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis.
Ariza J; Gudiol F; Pallarés R; Rufí G; Fernández-Viladrich P
Antimicrob Agents Chemother; 1985 Oct; 28(4):548-51. PubMed ID: 4073878
[TBL] [Abstract][Full Text] [Related]
7. Inadequate azithromycin activity against Brucella melitensis in mice with acute or chronic infections.
Domingo S; Gamazo C
J Chemother; 1996 Feb; 8(1):55-8. PubMed ID: 8835110
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM
J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379
[TBL] [Abstract][Full Text] [Related]
9. Investigation of antibiotic susceptibilities of Brucella Strains isolated from various clinical samples in eastern Turkey.
Gültekin E; Uyanık MH; Albayrak A; Kılıç S
Eur J Med Res; 2021 Jun; 26(1):57. PubMed ID: 34134763
[TBL] [Abstract][Full Text] [Related]
10. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.
Solera J; Rodríguez-Zapata M; Geijo P; Largo J; Paulino J; Sáez L; Martínez-Alfaro E; Sánchez L; Sepulveda MA; Ruiz-Ribó MD
Antimicrob Agents Chemother; 1995 Sep; 39(9):2061-7. PubMed ID: 8540716
[TBL] [Abstract][Full Text] [Related]
11. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study.
Ariza J; Gudiol F; Pallares R; Viladrich PF; Rufi G; Corredoira J; Miravitlles MR
Ann Intern Med; 1992 Jul; 117(1):25-30. PubMed ID: 1596044
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans Disease.
Converse PJ; Tyagi S; Xing Y; Li SY; Kishi Y; Adamson J; Nuermberger EL; Grosset JH
PLoS Negl Trop Dis; 2015; 9(6):e0003823. PubMed ID: 26042792
[TBL] [Abstract][Full Text] [Related]
13. In vitro antibacterial activity of tigecycline in comparison with doxycycline, ciprofloxacin and rifampicin against Brucella spp.
Turan H; Arslan H; Azap OK; Serefhanoğlu K; Uncu H
Int J Antimicrob Agents; 2007 Aug; 30(2):186-7. PubMed ID: 17462865
[No Abstract] [Full Text] [Related]
14. Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.
Ariza J; Bosch J; Gudiol F; Liñares J; Viladrich PF; Martín R
Antimicrob Agents Chemother; 1986 Dec; 30(6):958-60. PubMed ID: 3813520
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of ciprofloxacin versus doxycycline as prophylaxis against experimental murine Brucella melitensis infection.
Atkins HS; Spencer S; Brew SD; Jenner DC; Russell P; MacMillan AP; Eley SM; Simpson AJ
Int J Antimicrob Agents; 2009 Nov; 34(5):474-6. PubMed ID: 19500948
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of roxithromycin and azithromycin in experimental murine brucellosis.
Lang R; Shasha B; Ifrach N; Tinman S; Rubinstein E
Chemotherapy; 1994; 40(4):252-5. PubMed ID: 8082413
[TBL] [Abstract][Full Text] [Related]
17. In vitro efficacy of several antimicrobial combinations against Brucella canis and Brucella melitensis strains isolated from dogs.
Mateu-de-Antonio EM; Martín M
Vet Microbiol; 1995 Jun; 45(1):1-10. PubMed ID: 7653024
[TBL] [Abstract][Full Text] [Related]
18. The effect of long-term ethanol feeding on efficacy of doxycycline plus rifampicin in the treatment of experimental brucellosis caused by Brucella melitensis in rats.
Yumuk Z; Dundar V
J Chemother; 2005 Oct; 17(5):509-13. PubMed ID: 16323439
[TBL] [Abstract][Full Text] [Related]
19. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load.
Vrioni G; Bourdakis A; Pappas G; Pitiriga V; Mavrouli M; Pournaras S; Tsakris A
Antimicrob Agents Chemother; 2014 Dec; 58(12):7541-4. PubMed ID: 25246401
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice.
Domingo S; Díaz R; Gamazo C
FEMS Immunol Med Microbiol; 1995 Oct; 12(2):91-5. PubMed ID: 8589668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
